当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析 - 现金流量表

博雅生物

(300294)

  

流通市值:125.81亿  总市值:125.81亿
流通股本:5.04亿   总股本:5.04亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,326,624,834.33871,330,951.42408,351,390.041,602,340,771.62
  收到的税费返还--25,856.826,278,811.17
  收到其他与经营活动有关的现金36,381,215.2429,841,503.2818,818,375.8975,227,937.1
  经营活动现金流入小计1,363,006,049.57901,172,454.7427,195,622.751,683,847,519.89
  购买商品、接受劳务支付的现金556,386,378.2362,939,888.99195,595,093.65473,437,861.94
  支付给职工以及为职工支付的现金290,389,236.5204,998,492.12121,993,991.48299,372,152.6
  支付的各项税费165,421,983.06106,241,298.8940,660,974.78173,334,880.74
  支付其他与经营活动有关的现金324,697,809.93220,046,405.38111,065,059.46437,921,367.72
  经营活动现金流出小计1,336,895,407.69894,226,085.38469,315,119.371,384,066,263
  经营活动产生的现金流量净额26,110,641.886,946,369.32-42,119,496.62299,781,256.89
二、投资活动产生的现金流量:
  收回投资收到的现金4,645,065,066.712,232,899,001.821,430,000,0006,506,005,050
  取得投资收益收到的现金53,758,930.8129,224,495.9120,136,918.4191,259,626.12
  处置固定资产、无形资产和其他长期资产收回的现金净额2,098,306.711,706,908.5233,7281,821,936.89
  处置子公司及其他营业单位收到的现金净额158,160,797.81--239,607,090.61
  收到的其他与投资活动有关的现金---20,000,000
  投资活动现金流入小计4,859,083,102.042,263,830,406.251,450,170,646.416,858,693,703.62
  购建固定资产、无形资产和其他长期资产支付的现金412,844,043.06281,267,931.04119,475,659.29197,794,028.46
  投资支付的现金4,810,000,0002,200,000,0002,000,000,0005,530,496,527.8
  取得子公司及其他营业单位支付的现金---1,777,936,924.13
  投资活动现金流出小计5,222,844,043.062,481,267,931.042,119,475,659.297,506,227,480.39
  投资活动产生的现金流量净额-363,760,941.02-217,437,524.79-669,305,012.88-647,533,776.77
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,000,000---
  其中:子公司吸收少数股东投资收到的现金1,000,000---
  取得借款收到的现金1,162,988.7---
  收到其他与筹资活动有关的现金---5,237,675.71
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计2,162,988.7--5,237,675.71
  偿还债务支付的现金---73,995,860
  分配股利、利润或偿付利息支付的现金156,317,254.1580,679,798.08-232,409,473.2
  支付其他与筹资活动有关的现金44,955,158.663,476,007.111,696,873.992,306,484.8
  筹资活动现金流出小计201,272,412.8184,155,805.191,696,873.99308,711,818
  筹资活动产生的现金流量净额-199,109,424.11-84,155,805.19-1,696,873.99-303,474,142.29
四、汇率变动对现金及现金等价物的影响-57,739.96-7,950.9210,387.36-
五、现金及现金等价物净增加额-536,817,463.21-294,654,911.58-713,110,996.13-651,226,662.17
  加:期初现金及现金等价物余额1,298,571,389.971,298,571,389.971,298,571,389.971,949,798,052.14
  期末现金及现金等价物余额761,753,926.761,003,916,478.39585,460,393.841,298,571,389.97
补充资料:
  净利润-225,409,614.24-396,528,491.41
  资产减值准备-9,662,728.44-83,825,238.02
  固定资产和投资性房地产折旧-51,790,115.9-78,232,929.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-51,790,115.9-78,182,591.43
    投资性房地产折旧---50,338.01
  无形资产摊销-24,750,166.98-21,639,939.76
  长期待摊费用摊销-6,133,291.26-13,927,589.52
  递延收益摊销----4,010,596.08
  处置固定资产、无形资产和其他长期资产的损失--5,280,299.53-611,748.07
  固定资产报废损失-263,920.03-132,144
  公允价值变动损失--37,004,306.86--65,582,550.87
  财务费用-454,554.7--1,929,280.58
  投资损失--2,529,169.37--13,061,606.76
  递延所得税-6,722,503.98--6,223,228.54
  其中:递延所得税资产减少--3,592,418.83--5,528,237.65
    递延所得税负债增加-10,314,922.81--694,990.89
  存货的减少--23,694,524--120,059,964.7
  经营性应收项目的减少--239,741,023.85--211,491,523.01
  经营性应付项目的增加--12,013,108.27-116,589,093.05
  现金的期末余额-1,003,916,478.39-1,298,571,389.97
  减:现金的期初余额-1,298,571,389.97-1,949,798,052.14
  现金及现金等价物的净增加额--294,654,911.58--651,226,662.17
公告日期2025-10-282025-08-232025-04-252025-03-19
审计意见(境内)标准无保留意见
TOP↑